Cempra Pharma Raises $46 Million

Cempra Pharmaceuticals Inc., a Chapel Hill, N.C.-based developer of anti-infectives, has raised $46 million in Series C funding. Quaker BioVentures led the round, and was joined by Devon Park Bioventures and return backers Aisling Capital, Intersouth Partners, Teachers’ Private Capital and investment banker I. Wistar Morris III. The company previously raised around $32 million.

North AmericaUSBriefs